Market Outlook
The US Left Atrial Appendage Closure (LAAC) Devices Market was valued at approximately USD 1.82 billion in 2025 and is projected to reach nearly USD 4.76 billion by 2035, expanding at a CAGR of 10.08% during the forecast period 2026–2035. Historical analysis has been conducted from 2022 to 2024, with 2025 as the base year.
Left atrial appendage closure devices are increasingly adopted as an alternative to long-term oral anticoagulation therapy in patients with atrial fibrillation (AF), particularly non-valvular atrial fibrillation (NVAF). In the United States, atrial fibrillation affects over 6 million adults, and the number is projected to exceed 12 million by 2030. AF significantly increases stroke risk, with nearly 1 in 5 ischemic strokes attributed to atrial fibrillation. Because approximately 90% of stroke-causing clots in NVAF originate in the left atrial appendage, LAAC devices provide a targeted mechanical solution to reduce thromboembolic risk.
Growing concerns regarding bleeding complications from long-term anticoagulation, increasing awareness among electrophysiologists, expanding CMS reimbursement coverage, and favorable clinical trial evidence have collectively accelerated the adoption of LAAC procedures across major US cardiac centers.
Introduction
According to the US Left Atrial Appendage Closure Devices Market Report, the market is shaped by the intersection of structural heart innovation, stroke prevention strategies, and minimally invasive cardiology. The US healthcare system is increasingly prioritizing preventive cardiology, especially in high-risk AF populations who are contraindicated for chronic anticoagulation therapy.
The left atrial appendage is a small pouch in the left atrium where blood clots commonly form in AF patients. LAAC devices are designed to seal or exclude this appendage, thereby reducing stroke risk without the need for lifelong blood thinners. The clinical validation of LAAC devices through large randomized trials has strengthened physician confidence and payer acceptance.
The United States leads globally in LAAC adoption due to its advanced electrophysiology infrastructure, hybrid catheterization labs, strong regulatory oversight by the FDA, and CMS coverage policies supporting eligible patient populations.
Key Market Drivers: What’s Fueling the US Left Atrial Appendage Closure Devices Market Growth?
- Rising Prevalence of Atrial Fibrillation
Atrial fibrillation remains the most common sustained cardiac arrhythmia in the United States. The aging population, obesity trends, hypertension prevalence, and diabetes burden contribute to rising AF incidence. As the AF population grows, so does the eligible patient pool for LAA closure procedures. - Increased Stroke Prevention Awareness
Stroke remains a leading cause of long-term disability in the US. LAAC devices offer a compelling stroke risk reduction strategy, particularly for patients with elevated CHA₂DS₂-VASc scores and bleeding risk profiles. - Limitations of Oral Anticoagulants
While direct oral anticoagulants (DOACs) are effective, they carry bleeding risks and compliance challenges. Many elderly patients discontinue therapy due to adverse events, creating clinical demand for non-pharmacological alternatives. - Expanding CMS & Private Reimbursement
Medicare coverage for LAAC procedures has broadened under National Coverage Determinations (NCD), increasing access across US states. Private insurers are increasingly aligning coverage criteria with CMS standards.
Innovation in Focus: Advancements in LAA Closure Technology
Manufacturers are investing in next-generation occlusion devices with enhanced anchoring mechanisms, improved conformability to varying appendage anatomies, and reduced procedural complication rates.
Imaging advancements such as 3D transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE) have improved procedural precision. Real-time imaging guidance enhances device deployment accuracy and reduces peri-procedural risks.
Clinical trials are exploring expanded indications, including combination AF ablation and LAA closure in a single procedure, improving efficiency and patient convenience.
Recent Developments
Recent FDA approvals, expanded CMS coverage, and increasing electrophysiologist training programs are accelerating LAAC adoption. Combination AF ablation plus LAA closure procedures are gaining traction.
Device iteration improvements are reducing procedural complications and expanding patient eligibility.
Conclusion
The US Left Atrial Appendage Closure Devices Market Size & Share continues to expand as stroke prevention strategies evolve beyond pharmacological approaches. Growing AF prevalence, reimbursement support, technological innovation, and patient preference for non-drug therapies position the market for sustained double-digit growth through 2035.
The United States remains the global leader in LAAC adoption, supported by advanced structural heart programs and strong regulatory oversight.
Key Market Players
The US Left Atrial Appendage Closure Devices Competitive Landscape includes:
- Abbott Laboratories – Leading LAA closure technology provider with strong US presence.
- Boston Scientific – Expanding structural heart portfolio.
- Medtronic – Active in cardiac rhythm management and structural heart innovations.
- Johnson & Johnson (Biosense Webster) – Electrophysiology integration solutions.
- AtriCure – Surgical LAA exclusion systems.
- SentreHEART – Epicardial closure technologies.
- Conformal Medical – Next-generation LAA occlusion platform.
- Cardia – Occlusion device developer.
- Occlutech – Structural heart occluder technologies.
- Lifetech Scientific – Occlusion device manufacturer.
- W. L. Gore & Associates – Cardiovascular biomaterials.
- Cook Medical – Interventional device portfolio.
- Edwards Lifesciences – Structural heart innovations.
- Siemens Healthineers – Imaging integration solutions.
- GE HealthCare – Cardiovascular imaging platforms.
- Philips Healthcare – Cath lab imaging systems.
- MicroPort Scientific – Cardiovascular device portfolio.
- Transseptal Solutions – Access device innovators.
- Boston Medical Products – Cardiac procedural accessories.
- Terumo Cardiovascular – Structural heart support devices.
- Bayer Healthcare – Anticoagulation alternatives research.
- Pfizer – Stroke prevention therapeutics.
- Boehringer Ingelheim – AF anticoagulant therapies.
- Endocardial LAA Closure Devices
Endocardial devices dominate the US market. These are deployed via transseptal catheterization and are minimally invasive. They account for the largest revenue share due to established clinical evidence and strong electrophysiology adoption. - Epicardial LAA Closure Devices
Epicardial devices are typically used during surgical procedures or hybrid approaches. Although smaller in share, this segment is growing due to increasing hybrid cardiac interventions.
- Percutaneous/Transcatheter LAA Closure
Percutaneous LAAC is the fastest-growing and dominant segment. It is performed in catheterization labs under fluoroscopic and echocardiographic guidance. Major US cardiac centers perform thousands of such procedures annually. - Surgical LAA Closure
Surgical closure is commonly performed during concomitant cardiac surgeries such as valve replacement or coronary artery bypass grafting (CABG).
- Non-Valvular Atrial Fibrillation (NVAF)
NVAF represents the largest segment due to its strong association with LAA-originated thrombus formation. - Valvular Atrial Fibrillation
Smaller segment but relevant in patients with mechanical valves or rheumatic disease. - Others
Includes patients with contraindications to anticoagulants and high bleeding risk.
- Hospitals
Hospitals dominate due to need for advanced imaging, cath lab infrastructure, and multidisciplinary heart teams. - Cardiac Specialty Centers
High procedural volumes concentrated in metropolitan electrophysiology centers. - Ambulatory Surgical Centers
Limited but gradually expanding role in minimally invasive cardiac interventions.
West Region
The West region holds significant market share, led by California. California houses some of the highest procedural volumes due to large AF population and advanced electrophysiology programs in Los Angeles, San Diego, and San Francisco.
Washington and Colorado show strong growth supported by expanding cardiac centers. Arizona’s large retiree population drives AF prevalence and LAAC adoption. Oregon demonstrates steady growth through academic hospital participation.
Other West states including Nevada, Utah, and New Mexico are gradually expanding cardiac intervention capacity. Alaska and Hawaii represent smaller but stable markets.
Northeast Region
New York and Massachusetts are high-volume LAAC markets supported by academic institutions and Medicare-heavy populations. Pennsylvania and New Jersey demonstrate steady adoption rates.
Connecticut and Rhode Island show stable procedural growth. Maine, Vermont, and New Hampshire maintain smaller but expanding electrophysiology capabilities.
South Region
The South is the fastest-growing region. Texas leads in absolute procedure volumes due to its large population. Florida’s aging demographics strongly influence LAAC demand.
Georgia and North Carolina are emerging hubs for structural heart interventions. Tennessee and Alabama show steady expansion in catheterization lab capabilities.
States such as Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, and West Virginia show moderate but rising adoption driven by federal reimbursement support.
Midwest Region
Illinois and Ohio dominate regional share due to strong academic cardiology programs. Michigan and Minnesota are known for clinical research participation.
Indiana, Wisconsin, and Missouri show gradual but consistent LAAC procedure growth. Rural Midwest states maintain smaller volumes but increasing awareness.
1. US Left Atrial Appendage Closure Devices Market: Market Introduction & Context
1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.4 Analytical Frameworks & Forecasting End-Users
1.5 Data Validation and Final Report Publishing
1.6 Key Assumptions
1.7 Market Ecosystem Overview
1.8 Stakeholder Analysis (Manufacturers, Raw Material Suppliers, Distributors, Cardiac Centers, Regulatory Bodies, Payers)
What this section provides: This section introduces the scope, definitions, data sources, research methodology, validation framework, assumptions, and ecosystem mapping to ensure clarity, transparency, and reliability of the market study.
2. US Left Atrial Appendage Closure Devices Market: Executive Summary
2.1 Key Insights & Market Snapshot (2025–2035)
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index
2.4 Snapshot by Product Type
2.5 Snapshot by Procedure Type
2.6 Snapshot by Indication
2.7 Snapshot by End-User
2.8 Snapshot by Region
What this section provides: A concise yet strategic overview of the US LAAC devices market including size, CAGR, growth drivers, leading segments, and high-potential regions.
3. US Left Atrial Appendage Closure Devices Market: Market Dynamics & Outlook
3.1 Drivers and Impact Analysis
3.2 Restraints and Impact Analysis
3.3 Opportunities and Impact Analysis
3.4 Patent & Innovation Analysis (2020–2025)
3.5 Clinical Trials Landscape
3.6 Reimbursement & CMS Coverage Trends
What this section provides: Comprehensive analysis of key demand drivers, growth barriers, regulatory shifts, innovation pipeline, reimbursement evolution, and future opportunities shaping the market.
4. US Left Atrial Appendage Closure Devices Market: Market Environment & Industry Analysis
4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Substitution Risk
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Regulatory Framework Analysis (FDA & CMS)
4.6 Impact of Digitalization & Structural Heart Integration
4.7 Government & Federal Healthcare Initiatives
What this section provides: An in-depth macro and micro-environment analysis including regulatory influences, pricing shifts, competitive intensity, supply chain dynamics, and structural heart ecosystem evaluation.
5. US Left Atrial Appendage Closure Devices Market – By Product Type
5.1 Overview
5.2 Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.3 Endocardial LAA Closure Devices
5.4 Epicardial LAA Closure Devices
What this section provides: Detailed segmentation by device type, highlighting market dominance, technological differentiation, and revenue contribution forecasts.
6. US Left Atrial Appendage Closure Devices Market – By Procedure Type
6.1 Overview
6.2 Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.3 Percutaneous/Transcatheter LAA Closure
6.4 Surgical LAA Closure
What this section provides: Breakdown of procedure approaches with insights into adoption trends, hospital penetration, and minimally invasive growth trajectory.
7. US Left Atrial Appendage Closure Devices Market – By Indication
7.1 Overview
7.2 Segment Share Analysis, By Indication, 2025 & 2035 (%)
7.3 Non-Valvular Atrial Fibrillation (NVAF)
7.4 Valvular Atrial Fibrillation
7.5 Other High-Risk Stroke Indications
What this section provides: Analysis of clinical indications driving demand, with emphasis on NVAF population growth and stroke prevention needs.
8. US Left Atrial Appendage Closure Devices Market – By End-User
8.1 Overview
8.2 Segment Share Analysis, By End-User, 2025 & 2035 (%)
8.3 Hospitals
8.4 Cardiac Specialty Centers
8.5 Ambulatory Surgical Centers
What this section provides: Evaluation of demand patterns across healthcare facilities and structural heart program expansion.
9. US Left Atrial Appendage Closure Devices Market – By Geography
9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.3 West Region
9.3.1 Regional Overview & Trends
9.3.2 Market Size & Forecast, By State, 2025–2035 (US$ Million)
9.3.2.1 California
9.3.2.2 Washington
9.3.2.3 Colorado
9.3.2.4 Arizona
9.3.2.5 Oregon
9.3.2.6 Utah
9.3.2.7 Nevada
9.3.2.8 New Mexico
9.3.2.9 Idaho
9.3.2.10 Montana
9.3.2.11 Wyoming
9.3.2.12 Alaska
9.3.2.13 Hawaii
9.4 Northeast Region
9.4.1 Regional Overview & Trends
9.4.2 Market Size & Forecast, By State
9.4.2.1 New York
9.4.2.2 Massachusetts
9.4.2.3 New Jersey
9.4.2.4 Pennsylvania
9.4.2.5 Connecticut
9.4.2.6 Maine
9.4.2.7 Vermont
9.4.2.8 New Hampshire
9.4.2.9 Rhode Island
9.4.2.10 Delaware
9.5 South Region
9.5.1 Regional Overview & Trends
9.5.2 Market Size & Forecast, By State
9.5.2.1 Texas
9.5.2.2 Florida
9.5.2.3 Georgia
9.5.2.4 North Carolina
9.5.2.5 Tennessee
9.5.2.6 South Carolina
9.5.2.7 Alabama
9.5.2.8 Mississippi
9.5.2.9 Louisiana
9.5.2.10 Arkansas
9.5.2.11 Kentucky
9.5.2.12 Oklahoma
9.5.2.13 Maryland
9.5.2.14 Virginia
9.5.2.15 West Virginia
9.6 Midwest Region
9.6.1 Regional Overview & Trends
9.6.2 Market Size & Forecast, By State
9.6.2.1 Illinois
9.6.2.2 Ohio
9.6.2.3 Michigan
9.6.2.4 Minnesota
9.6.2.5 Indiana
9.6.2.6 Wisconsin
9.6.2.7 Missouri
9.6.2.8 Iowa
9.6.2.9 Kansas
9.6.2.10 Nebraska
9.6.2.11 North Dakota
9.6.2.12 South Dakota
What this section provides: Comprehensive region-wise and state-level market analysis highlighting procedural volumes, reimbursement environment, AF prevalence, healthcare infrastructure maturity, and structural heart program expansion across all US states.
10. US Left Atrial Appendage Closure Devices Market: Competitive Landscape & Company Profiles
10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Company Profiles
10.3.1 Abbott Laboratories
10.3.2 Boston Scientific Corporation
10.3.3 Medtronic plc
10.3.4 Johnson & Johnson (Biosense Webster)
10.3.5 AtriCure, Inc.
10.3.6 SentreHEART, Inc.
10.3.7 Conformal Medical, Inc.
10.3.8 Cardia, Inc.
10.3.9 Occlutech Holding AG
10.3.10 Lifetech Scientific Corporation
10.3.11 W. L. Gore & Associates
10.3.12 Cook Medical
10.3.13 Edwards Lifesciences Corporation
10.3.14 Terumo Cardiovascular Systems
10.3.15 MicroPort Scientific Corporation
10.3.16 Siemens Healthineers
10.3.17 GE HealthCare
10.3.18 Philips Healthcare
10.3.19 Transseptal Solutions LLC
10.3.20 Boston Medical Products, Inc.
10.3.21 Baylis Medical (Teleflex)
10.3.22 Lepu Medical Technology
10.3.23 EBR Systems
10.3.24 Shanghai Shape Memory Alloy Co.
10.3.25 Others
What this section provides: Detailed competitor benchmarking, US market presence, portfolio analysis, strategic developments, and innovation positioning.
11. US Left Atrial Appendage Closure Devices Market: Future Market Outlook (2025–2035)
11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Emerging Structural Heart Innovations
11.3 Combination Therapy Trends
11.4 Investment & M&A Outlook
What this section provides: Forward-looking insights into disruptive technologies, adoption scenarios, partnership activity, and long-term revenue trajectory.
12. US Left Atrial Appendage Closure Devices Market: Strategic Recommendations
What this section provides: Actionable growth strategies for device manufacturers, investors, hospital administrators, and new market entrants.
13. US Left Atrial Appendage Closure Devices Market: Disclaimer
What this section provides: Legal, methodological, and liability clarifications governing use of the report.
List of Tables
TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Left Atrial Appendage Closure Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Left Atrial Appendage Closure Devices Market: Procedure Type Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 9: US Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 10: US Left Atrial Appendage Closure Devices Market: Indication Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Indication
TABLE 12: US Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 13: US Left Atrial Appendage Closure Devices Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: US Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 16: US Left Atrial Appendage Closure Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Left Atrial Appendage Closure Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 21: California Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 22: California Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 25: Washington Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 26: Washington Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 29: Colorado Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 30: Colorado Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 33: Arizona Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 34: Arizona Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 37: Oregon Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 38: Oregon Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 41: West – Others Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 42: West – Others Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 45: New York Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 46: New York Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 49: Massachusetts Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 50: Massachusetts Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 53: New Jersey Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 54: New Jersey Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 61: Connecticut Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 62: Connecticut Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 69: Texas Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 70: Texas Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 73: Florida Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 74: Florida Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 77: Georgia Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 78: Georgia Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 81: North Carolina Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 82: North Carolina Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 85: Tennessee Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 86: Tennessee Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 89: South Carolina Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 90: South Carolina Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 93: Alabama Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 94: Alabama Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 97: South – Others Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 98: South – Others Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 101: Illinois Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 102: Illinois Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 105: Ohio Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 106: Ohio Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 109: Michigan Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 110: Michigan Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 113: Minnesota Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 114: Minnesota Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 117: Indiana Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 118: Indiana Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 121: Wisconsin Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 122: Wisconsin Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 125: Missouri Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 126: Missouri Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Left Atrial Appendage Closure Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Left Atrial Appendage Closure Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Left Atrial Appendage Closure Devices Market, by Indication, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Left Atrial Appendage Closure Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)
List of Figures
FIGURE 1: US Left Atrial Appendage Closure Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTLE Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2025)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Procedure Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Indication Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Indication Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region US Left Atrial Appendage Closure Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region US Left Atrial Appendage Closure Devices Market Share and Leading Players, 2025
FIGURE 22: South Region US Left Atrial Appendage Closure Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region US Left Atrial Appendage Closure Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Left Atrial Appendage Closure Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
